Trials / Active Not Recruiting
Active Not RecruitingNCT06765694
Efficacy of One or Two Botulinum Toxin Injections in the Treatment of Chronic Lateral Epicondylalgia: a Retrospective Study (EPITOX)
Efficacy of One or Two Botulinum Toxin Injections in the Treatment of Chronic Lateral Epicondylalgia: a Retrospective Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Despite being a self-limiting injury, lateral epicondylitis (LE) can be difficult to manage. In cases of refractory LE, conservative treatment fails and symptoms persist over 6 months. Previous studies have investigated the role of botulinum Toxin Type A (BoNT-A) injections in LE with controversial results. There is some evidence that repeating the BoNT-A injection could be beneficial for refractory cases. The objective is to assess the success rate of one or two BoNT-A injections for refractory LE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin injection | first injection was done under ultrasound control in the extensor carpi radialis brevis (ECRB). The second one if necessary was subordinated to clinical examination and focused in one or more of the following: ECRB, extensor digitorum communis, supinator. |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-10-31
- Completion
- 2025-10-31
- First posted
- 2025-01-09
- Last updated
- 2025-01-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06765694. Inclusion in this directory is not an endorsement.